|Bid||6.86 x 1000|
|Ask||7.69 x 1100|
|Day's Range||6.85 - 7.34|
|52 Week Range||5.26 - 11.01|
|Beta (5Y Monthly)||2.43|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Sep 11, 2017|
|1y Target Est||N/A|
The biotech has already seen its shares buffeted by issues with an experimental Alzheimer’s drug. Now it faces a decision that could hasten generic producers taking a bite out of 40% of its revenues.
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Our research shows that most of the stocks that smart money likes historically generate strong […]
As an investor, mistakes are inevitable. But really bad investments should be rare. So take a moment to sympathize...